Mostafa Adam S.

CIK 00017380812 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001738081

Recent Transactions

38 trades

Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2025-02-12+850,000→ 850,000 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2025-01-24$0.45/sh−74,773→ 0 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2025-01-23+74,773→ 74,773 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2024-10-07$0.55/sh−230,645→ 0 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2024-10-04+230,645→ 230,645 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2024-03-11$0.88/sh−52,500→ 0 total
Award
X4 Pharmaceuticals, Inc$XFOR
Stock Appreciation Right
2024-02-13+523,414→ 523,414 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2024-02-12$1.01/sh−27,721→ 52,500 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2023-11-01$0.73/sh−230,645→ 80,221 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2023-10-31+230,645→ 310,866 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2023-06-30$1.89/sh−2,641→ 80,221 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2023-06-23$1.93/sh−5,417→ 82,862 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2023-06-15$2.22/sh−5,417→ 88,279 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2023-03-10$0.84/sh−52,500→ 93,696 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2023-02-13$0.93/sh−27,721→ 146,196 total
Award
X4 Pharmaceuticals, Inc$XFOR
Stock Appreciation Right
2022-11-07+1,350,000→ 1,350,000 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2022-08-17−10,834→ 173,917 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2022-06-30−2,641→ 184,751 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2022-06-24−5,416→ 187,392 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2022-06-16−5,416→ 192,808 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2022-03-01+105,000→ 198,224 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2022-02-11−27,721→ 93,224 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2021-08-17$5.10/sh−10,832→ 120,945 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2021-06-30$6.64/sh−2,641→ 131,777 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2021-06-24$7.01/sh−5,417→ 134,418 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2021-06-23+16,250→ 139,835 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2021-06-15+16,250→ 129,002 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2021-06-15$7.84/sh−5,417→ 123,585 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2021-03-24+83,163→ 112,752 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2020-09-21$7.08/sh−10,834→ 29,589 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2020-08-17+16,250→ 40,423 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2020-08-14+16,250→ 24,173 total
Tax Payment
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2020-06-30$9.32/sh−916→ 7,923 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2020-06-30$9.04/sh−1,725→ 8,839 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2019-06-17+10,564→ 10,564 total
Award
X4 Pharmaceuticals, Inc$XFOR
Stock Option (right to buy)
2019-06-17+15,847→ 15,847 total
Award
X4 Pharmaceuticals, Inc$XFOR
Stock Option (right to buy)
2019-03-13+62,633→ 62,633 total
Award
X4 Pharmaceuticals, Inc$XFOR
Stock Option (right to buy)
2019-03-13+62,633→ 62,633 total

Mostafa Adam S.

Recent Transactions

Companies

Recent Filings

Address